Literature DB >> 15483658

Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials.

R S Foti1, M B Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15483658     DOI： 10.1038/sj.tpj.6500286

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  2 in total

1.  Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation.

Authors:  Martin F Fromm; Helmut Schwilden; Iouri Bachmakov; Jörg König; Frank Bremer; Jürgen Schüttler
Journal:  Eur J Clin Pharmacol       Date:  2007-09-05       Impact factor: 2.953

2.  African variation at Cytochrome P450 genes: Evolutionary aspects and the implications for the treatment of infectious diseases.

Authors:  Ripudaman K Bains
Journal:  Evol Med Public Health       Date:  2013-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.